当前位置:首页 - 行情中心 - 峆一药业(920478) - 财务分析 - 现金流量表

峆一药业

(920478)

  

流通市值:7.43亿  总市值:12.37亿
流通股本:4724.01万   总股本:7870.87万

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金65,225,480.46273,848,423.08246,352,888.42185,289,389.8
  收到的税费返还2,352,886.0819,476,765.5915,414,548.4610,829,843.03
  收到其他与经营活动有关的现金1,154,357.22,028,734.194,703,819.582,281,261.45
  经营活动现金流入小计68,732,723.74295,353,922.86266,471,256.46198,400,494.28
  购买商品、接受劳务支付的现金30,834,777.84119,781,841.1123,954,978.3687,875,030.41
  支付给职工以及为职工支付的现金16,459,655.8455,248,524.7441,781,200.0327,933,538.99
  支付的各项税费3,217,225.3923,589,949.6815,267,208.2210,852,305.73
  支付其他与经营活动有关的现金7,770,716.5121,168,110.7818,820,756.7111,693,599.29
  经营活动现金流出小计58,282,375.58219,788,426.3199,824,143.32138,354,474.42
  经营活动产生的现金流量净额10,450,348.1675,565,496.5666,647,113.1460,046,019.86
二、投资活动产生的现金流量:
  收回投资收到的现金83,000,000434,000,000370,000,000252,000,000
  取得投资收益收到的现金533,528.882,895,885.522,591,621.141,796,012.44
  处置固定资产、无形资产和其他长期资产收回的现金净额-932.72950890
  收到的其他与投资活动有关的现金96,177.23-340,883.9781,585.32
  投资活动现金流入小计83,629,706.11436,896,818.24372,933,455.11253,878,487.76
  购建固定资产、无形资产和其他长期资产支付的现金55,321,258116,397,772.26111,412,987.4677,697,769.65
  投资支付的现金118,838,800380,330,000315,330,000213,330,000
  投资活动现金流出小计174,160,058496,727,772.26426,742,987.46291,027,769.65
  投资活动产生的现金流量净额-90,530,351.89-59,830,954.02-53,809,532.35-37,149,281.89
三、筹资活动产生的现金流量:
  取得借款收到的现金24,324,193.737,461,814.8929,774,114.8916,202,514.89
  筹资活动现金流入小计24,324,193.737,461,814.8929,774,114.8916,202,514.89
  分配股利、利润或偿付利息支付的现金-22,488,20022,488,20022,488,200
  支付其他与筹资活动有关的现金2,273,942.066,512,518.716,296,766.486,673,837.93
  筹资活动现金流出小计2,273,942.0629,000,718.7128,784,966.4829,162,037.93
  筹资活动产生的现金流量净额22,050,251.648,461,096.18989,148.41-12,959,523.04
四、汇率变动对现金及现金等价物的影响71,360.431,135,331.731,146,003.42909,071.61
五、现金及现金等价物净增加额-57,958,391.6625,330,970.4514,972,732.6210,846,286.54
  加:期初现金及现金等价物余额95,034,509.1469,703,538.6969,703,538.6969,703,538.69
  期末现金及现金等价物余额37,076,117.4895,034,509.1484,676,271.3180,549,825.23
补充资料:
  净利润-44,645,913.6-38,455,298.38
  资产减值准备-3,087,468.69--161,456.34
  固定资产和投资性房地产折旧-21,214,858.2-10,342,251.74
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-21,214,858.2-10,342,251.74
  无形资产摊销-775,640.32-387,820.16
  长期待摊费用摊销-1,269,619.9-354,351.62
  固定资产报废损失-16,203.73-11,502.28
  公允价值变动损失-650,284.7-606,856
  财务费用--1,058,652.49--927,414.19
  投资损失--2,637,269.58--1,796,012.44
  递延所得税--444,160.06--301,721.26
  其中:递延所得税资产减少--444,545.1--312,222.93
    递延所得税负债增加-385.04-10,501.67
  存货的减少--3,201,671.85--792,402.46
  经营性应收项目的减少-1,731,131.26-6,592,091.63
  经营性应付项目的增加-4,603,585.26-4,995,365.76
  其他-4,081,440.64-2,040,720.33
  现金的期末余额-95,034,509.14-80,549,825.23
  减:现金的期初余额-69,703,538.69-69,703,538.69
  现金及现金等价物的净增加额-25,330,970.45-10,846,286.54
公告日期2026-04-282026-04-162025-10-282025-08-19
审计意见(境内)标准无保留意见
TOP↑